{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-03-18",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "status": "Terminated",
      "city": "Monmouth Junction",
      "state": "NJ",
      "country": "United States",
      "classification": "Class II",
      "openfda": {},
      "product_type": "Drugs",
      "event_id": "81960",
      "recalling_firm": "Tris Pharma Inc.",
      "address_1": "2033 US Highway 130",
      "address_2": "N/A",
      "postal_code": "08852-3003",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "initial_firm_notification": "Letter",
      "distribution_pattern": "One distributor who further distributed Nationwide in the USA.",
      "recall_number": "D-0494-2019",
      "product_description": "infants* IBUPROFEN, Concentrated Ibuprofen Oral Suspension, USP (NSAID), 50 mg per 1.25 mL, Dye-Free Berry Flavor, 1 FL OZ (30 mL) bottle, Distributed by Wal-Mart Stores, Inc., Bentonville, AR 72716, NDC 49035-125-24.",
      "product_quantity": "35,328 bottles",
      "reason_for_recall": "Superpotent Drug: recalled lots may have higher concentration of ibuprofen than amount labeled.",
      "recall_initiation_date": "20190115",
      "center_classification_date": "20190214",
      "termination_date": "20230329",
      "report_date": "20190220",
      "code_info": "Lot#: 00717005A, Exp 02/19"
    }
  ]
}